 |
PDBsum entry 4ztz
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
DNA binding protein/DNA
|
PDB id
|
|
|
|
4ztz
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
DNA binding protein/DNA
|
 |
|
Title:
|
 |
Structural basis for processivity and antiviral drug toxicity in human mitochondrial DNA replicase
|
|
Structure:
|
 |
DNA polymerase subunit gamma-1. Chain: a. Fragment: unp residues 30-1239. Synonym: mitochondrial DNA polymerase catalytic subunit,polg-alpha. Engineered: yes. DNA polymerase subunit gamma-2, mitochondrial. Chain: b, c. Synonym: DNA polymerase gamma accessory 55 kda subunit,p55, mitochondrial DNA polymerase accessory subunit,mtpolb,polg-beta.
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Gene: polg, mdp1, polg1, polga. Expressed in: insect cell expression vector ptie1. Expression_system_taxid: 266783. Gene: polg2, mtpolb. Synthetic: yes. Synthetic construct.
|
|
Resolution:
|
 |
|
3.44Å
|
R-factor:
|
0.281
|
R-free:
|
0.320
|
|
|
Authors:
|
 |
M.R.Szymanski,Y.W.Yin
|
|
Key ref:
|
 |
M.R.Szymanski
et al.
(2015).
Structural basis for processivity and antiviral drug toxicity in human mitochondrial DNA replicase.
Embo J,
34,
1959-1970.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
15-May-15
|
Release date:
|
23-Sep-15
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class 1:
|
 |
Chain A:
E.C.2.7.7.7
- DNA-directed Dna polymerase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
DNA(n) + a 2'-deoxyribonucleoside 5'-triphosphate = DNA(n+1) + diphosphate
|
 |
 |
 |
 |
 |
DNA(n)
|
+
|
2'-deoxyribonucleoside 5'-triphosphate
|
=
|
DNA(n+1)
|
+
|
diphosphate
|
|
 |
 |
 |
 |
 |
 |
 |
 |
Enzyme class 2:
|
 |
Chains B, C:
E.C.?
|
|
 |
 |
 |
 |
 |
 |
 |
|
Note, where more than one E.C. class is given (as above), each may
correspond to a different protein domain or, in the case of polyprotein
precursors, to a different mature protein.
|
|
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
Embo J
34:1959-1970
(2015)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structural basis for processivity and antiviral drug toxicity in human mitochondrial DNA replicase.
|
|
M.R.Szymanski,
V.B.Kuznetsov,
C.Shumate,
Q.Meng,
Y.S.Lee,
G.Patel,
S.Patel,
Y.W.Yin.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The human DNA polymerase gamma (Pol γ) is responsible for DNA replication in
mitochondria. Pol γ is particularly susceptible to inhibition by
dideoxynucleoside-based inhibitors designed to fight viral infection. Here, we
report crystal structures of the replicating Pol γ-DNA complex bound to either
substrate or zalcitabine, an inhibitor used for HIV reverse transcriptase. The
structures reveal that zalcitabine binds to the Pol γ active site almost
identically to the substrate dCTP, providing a structural basis for Pol
γ-mediated drug toxicity. When compared to the apo form, Pol γ undergoes
intra- and inter-subunit conformational changes upon formation of the ternary
complex with primer/template DNA and substrate. We also find that the accessory
subunit Pol γB, which lacks intrinsic enzymatic activity and does not contact
the primer/template DNA directly, serves as an allosteric regulator of
holoenzyme activities. The structures presented here suggest a mechanism for
processivity of the holoenzyme and provide a model for understanding the
deleterious effects of Pol γ mutations in human disease. Crystal structures of
the mitochondrial DNA polymerase, Pol γ, in complex with substrate or antiviral
inhibitor zalcitabine provide a basis for understanding Pol γ-mediated drug
toxicity.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |
|